Delivery Order SPE2DB22D1002-SPE2DB24FLDZ9

Award Date 6/25/24
Potential Completion Date 6/26/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $2,049.52 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of M-M-R II vaccine vials. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $2,561.90 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. This order is for the supply of M-M-R II vaccine vials, with an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,347.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of M-M-R II vaccine vials and has a completion date of February 27, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,714.71 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,196.97 firm fixed price delivery order is for the supply of M-M-R II vaccine vials, with a period of performance through May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a wide range of pharmaceutical products...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $26,939.38 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This order is part of a broader Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order worth $10,137.49 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,798.16 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of M-M-R II vaccine vials, with a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Delivery Order contract worth $2,129.44 for the provision of pharmaceutical products and medical supplies. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA to deliver a comprehensive range of medications, including specialty, brand name, generic, and over-the-counter drugs,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $4,785.12 fixed-price contract is for the supply of M-M-R II vaccine vials, with a period of performance through May 8, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLDZ9
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,049.52 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of M-M-R II vaccine vials and does not have a set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/24/24, 9:20 AM